As of 31 Dec 2025, 1 institutional investors reported holding 140 shares of Ginkgo Bioworks Holdings, Inc. - Stock (DNABW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 140 | $1 | $0.01 | 1 | |
| 2025 Q3 | 140 | $1 | -$1 | $0.01 | 1 |
| 2025 Q2 | 200 | $3 | $0.02 | 2 | |
| 2025 Q1 | 200 | $2 | -$3,658 | $0.01 | 2 |
| 2024 Q4 | 576,545 | $3,660 | -$291 | $0.01 | 3 |
| 2024 Q3 | 641,394 | $3,910 | -$214,096 | $0.01 | 4 |
| 2024 Q2 | 8,244,589 | $232,496 | +$2,973 | $0.03 | 24 |
| 2024 Q1 | 7,774,956 | $699,720 | -$15,568 | $0.09 | 25 |
| 2023 Q4 | 7,854,383 | $827,079 | -$38,234 | $0.11 | 31 |
| 2023 Q3 | 7,732,079 | $1,739,767 | +$102,522 | $0.22 | 31 |
| 2023 Q2 | 7,252,230 | $1,901,912 | -$1,491 | $0.26 | 32 |
| 2023 Q1 | 5,697,596 | $1,026,227 | -$73,200 | $0.18 | 37 |
| 2022 Q4 | 6,051,567 | $1,210,218 | -$1,870,878 | $0.20 | 40 |
| 2022 Q3 | 7,678,220 | $5,531,000 | -$203,232 | $0.72 | 36 |
| 2022 Q2 | 7,983,447 | $4,230,000 | -$1,250,214 | $0.53 | 35 |
| 2022 Q1 | 9,715,003 | $8,557,000 | -$6,278,788 | $0.88 | 35 |
| 2021 Q4 | 12,509,092 | $28,044,000 | -$4,813,233 | $2.24 | 46 |
| 2021 Q3 | 11,367,835 | $38,535,000 | +$38,532,000 | $3.39 | 61 |